Compile Data Set for Download or QSAR
Report error Found 185 Enz. Inhib. hit(s) with all data for entry = 3145
TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392953(US10301306, Example 151)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392942(US10301306, Example 140)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392940(US10301306, Example 138)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392939(US10301306, Example 137)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392816(5-Fluoro-2-((4-oxo-2-(pyridin-4-yl)-3-(thiophen-2-...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392816(5-Fluoro-2-((4-oxo-2-(pyridin-4-yl)-3-(thiophen-2-...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392944(US10301306, Example 142)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392815(3-(4-Fluorophenyl)-1-(4-(3-methyl-1,2,4-oxadiazol-...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392943(US10301306, Example 141)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392966(US10301306, Example 164)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392836(US10301306, Example 34)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392902(US10301306, Example 161 | US10301306, Example 100)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392840(US10301306, Example 38)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392958(N-(4-(1-(2-Fluoro-4-(trifluoromethyl)benzyl)-3-(4-...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392829(US10301306, Example 27)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392955(3-(4-Fluorophenyl)-7,7-dimethyl-2-(pyridin-4-yl)-6...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392962(US10301306, Example 160)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392961(US10301306, Example 159)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392959(1-(2-Fluoro-4-(trifluoromethyl)benzyl)-3-(4-fluoro...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392853(US10301306, Example 51)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392857(US10301306, Example 55)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392985(US10301306, Example 183)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392855(US10301306, Example 53)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392846(US10301306, Example 44)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392845(US10301306, Example 43)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392843(US10301306, Example 41)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392850(US10301306, Example 48)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392848(US10301306, Example 46)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392870(US10301306, Example 68)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392868(US10301306, Example 66)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392867(US10301306, Example 65)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392873(US10301306, Example 71)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392866(US10301306, Example 64)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392886(US10301306, Example 84)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392877(US10301306, Example 75)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392876(US10301306, Example 74)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392875(US10301306, Example 73)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392880(US10301306, Example 78)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392879(US10301306, Example 77)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392902(US10301306, Example 161 | US10301306, Example 100)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392903(US10301306, Example 101)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392917(US10301306, Example 115)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392806(N-(4-(3-(4-Fluorophenyl)-1-(4-methylbenzyl)-4-oxo-...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392932(US10301306, Example 130)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392804(3-((3-(4-Fluorophenyl)-4-oxo-2-(pyridin-4-yl)-4,5,...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392938(US10301306, Example 136)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392810(N-(4-(1-(2-Fluoro-4-(trifluoromethyl)benzyl)-3-(4-...)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392936(US10301306, Example 134)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392926(US10301306, Example 124)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

TargetReceptor-interacting serine/threonine-protein kinase 3(Human)
Bristol-Myers Squibb

US Patent
LigandPNGBDBM392925(US10301306, Example 123)
Affinity DataIC50: 30nMAssay Description:The assays were performed in black 1536-well plates. The final assay volume of 2 μl contained a mixture of a fluorescently labeled HTRF probe, T...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2020
Entry Details
Go to US Patent

Displayed 1 to 50 (of 185 total ) | Next | Last >>
Jump to: